Reportedly Allergan and Merck have made preliminary informal expressions of takeover interest for Biogen - pres
Pokémon Go hits 100M downloads, earns $10M/day, as company explains third-party service block
There seems no end to Pokémon Go mania as App Annie notes that the app has now hit 100M downloads and is still earning a cool $10M a day some three weeks after launch.
Apple had previously said that the app had set a new record for launch week downloads, but had not revealed the number – though one analyst estimated that the game could be worth as much as $3B to Apple over a 1-2 year timeframe. Interestingly, that success doesn’t appear to be at the expense of other games, as overall revenues across all games saw dropped only briefly.
Pokémon Go has not had a sustained and meaningful impact on the daily revenue of other games on iOS and Google Play. Daily revenue for Games other than Pokémon GO did see a brief dip in the US shortly after the game’s launch, but quickly climbed back to previous levels in a few days.
Indeed, the analytics company believes that the popularity of the game represents an opportunity for other developers as it has popularized the concept of augmented reality and demonstrated to businesses the value of sponsorships …
Game developers could make a limited amount of in-game items (or virtual currency) available at specific retail stores or local businesses who in turn would pay for the increased foot traffic. This could help mobile game publishers monetize a much larger percentage of their user base and create an entirely new revenue stream.
Some players were disappointed when Niantic shut down third-party services like PokeVision, and the company has now explained the reason for this.
We have limited access by third-party services which were interfering with our ability to maintain quality of service for our users and to bring Pokémon GO to users around the world. The large number of users has made the roll-out of Pokémon GO around the world an… interesting… challenge.
The company also said that it is working hard to bring the game to other countries, giving a specific mention to Brazil.
The block on third-party services isn’t preventing all unofficial access to the game, however, as one Tesla hacker demonstrated …
Choice Hotels beats by $0.04, reports revs in-line; guides Q3 EPS in-line; guides FY16 EPS above consensus
- Reports Q2 (Jun) earnings of $0.71 per share, excluding non-recurring items, $0.04 better than the Capital IQ Consensus of $0.67; revenues rose 4.1% year/year to $241.75 mln vs the $243.26 mln Capital IQ Consensus.
- Co issues in-line guidance for Q3, sees EPS of 'at least' $0.78, excluding non-recurring items, vs. $0.82 Capital IQ Consensus Estimate.
- Co issues upside guidance for FY16, sees EPS of $2.38-2.43, excluding non-recurring items, vs. $2.32 Capital IQ Consensus Estimate. EBITDA is expeted to be in the range of $252-256 mln.
- Net domestic unit growth for 2016 is expected to be between 2% and 3%;
- RevPAR is expected to increase between 3.5% and 4.0% for third quarter and range between 3.5% and 4.0% for full-year 2016;
- The effective royalty rate is expected to increase between 7 and 9 basis points for full-year 2016 as compared to full-year 2015
Gapping down
In reaction to disappointing earnings/guidance: BCEI -29.1%, (also plans to suspend asset sale process; elects not to make interest payment on 5.75% Senior Unsecured Note), IDTI -17.1%, RAIL -11.8%, IQNT -11.4%, TXRH -10.7%, TTOO-9.8%, ALLT -5.7%, EIGI -5.6%, BGSF -5.5%, QUAD -4.9%, CIE -4.4%, EMR -3.9%, EMR -3.9%, MZOR -3.8%, FTR -3.7%,MLM -3.2%, THC -3.1%, ADM -2.8%, MOS -2.4%, CGEN -1.6%, PFE -1.5%, APTS -1.2%, H -1%, ATKR -0.5%
Select EU financial names showing weakness in sympathy with DB and CS: SAN -3.9%, ING -3.6%, BBVA -3.2%, LYG-0.4%
Other news:
In reaction to disappointing earnings/guidance: BCEI -29.1%, (also plans to suspend asset sale process; elects not to make interest payment on 5.75% Senior Unsecured Note), IDTI -17.1%, RAIL -11.8%, IQNT -11.4%, TXRH -10.7%, TTOO-9.8%, ALLT -5.7%, EIGI -5.6%, BGSF -5.5%, QUAD -4.9%, CIE -4.4%, EMR -3.9%, EMR -3.9%, MZOR -3.8%, FTR -3.7%,MLM -3.2%, THC -3.1%, ADM -2.8%, MOS -2.4%, CGEN -1.6%, PFE -1.5%, APTS -1.2%, H -1%, ATKR -0.5%
Select EU financial names showing weakness in sympathy with DB and CS: SAN -3.9%, ING -3.6%, BBVA -3.2%, LYG-0.4%
Other news:
- ANGO -9.2% (commences 2.25 mln common stock offering by selling shareholdders, Avista Capital Partners, LP and affiliated investment funds )
- GLOP -7.1% (prices offering of 2,750,000 common units at a price to the public of $19.50 per common unit , FELP -4.2% (Foresight Energy launches numerous transactions in connection with its proposed global restructuring)
- CS -3.7% (removed from the STOXX Europe 50 Index),
- AQMS -3.5% (files ~4.431 mln share common stock offering by selling stockholders)
- PTN -2.9% (priced underwritten offering of units with anticipated gross proceeds of $9.25 mln),
- BRX -2.4% (announces secondary offering of 30,000,000 shares of common stock )
- DB -2.2% (removed from the STOXX Europe 50 Index),
- ELLI -1.8% (commenced an underwritten registered public follow-on offering of 2,750,000 shares of its common stock),
- SNY -1.6% (in sympathy with PFE)
- ITEK -1.2% (announces pricing of underwritten public offering of $50.0 million aggregate principal amount of 5.75% Convertible Senior Notes due 2021), ITEK -1.2%, .
Analyst comments:
- SCTY -1.3% (downgraded to Neutral at Robert W. Baird; downgraded to Mkt Perform at Raymond James)
- BWLD -1.3% (downgraded to Hold at Maxim Group)
- WEN -0.9% (downgraded to Sector Perform at RBC Capital Mkts)
Gapping up
In reaction to strong earnings/guidance: HBP +19%, CGNX +14.7%, AMKR +14%, SODA +12.6%, NLS +11.7%, AVP+9.9%, CARB +9%, VECO +6.9%, MNK +6.9%, GKOS +6.4%, SALE +6.4%, RYAM +6.2%, AEIS +5.5%, BIOC +5.3%,WMB +4.3%, TSE +4.1%, SHPG +4%, WPZ +3.8%, IDXX +3.8%, XOXO +3.7%, PLOW +3.7%, TNET +3%, ATW +3%,CHGG +2.9%, AVGR +2.4%, OMEX +2.4%, (thinly traded), GAIN +2.3%, HMC +2.2%, WNR +2.2%, ABC +2%, WCG+2%, DNB +1.9%, IPI +1.8%, DAC +1.7%, CVS +1.6%, ETR +1.5%, NRZ +1.5%, AET +1.4%, ENOC +1.4%, STX+1.4%, PG +1.2%, VGZ +1.2%, PRSC +1.1%, SBRA +1%, TST +0.9%, DISCA +0.9%
M&A news:
In reaction to strong earnings/guidance: HBP +19%, CGNX +14.7%, AMKR +14%, SODA +12.6%, NLS +11.7%, AVP+9.9%, CARB +9%, VECO +6.9%, MNK +6.9%, GKOS +6.4%, SALE +6.4%, RYAM +6.2%, AEIS +5.5%, BIOC +5.3%,WMB +4.3%, TSE +4.1%, SHPG +4%, WPZ +3.8%, IDXX +3.8%, XOXO +3.7%, PLOW +3.7%, TNET +3%, ATW +3%,CHGG +2.9%, AVGR +2.4%, OMEX +2.4%, (thinly traded), GAIN +2.3%, HMC +2.2%, WNR +2.2%, ABC +2%, WCG+2%, DNB +1.9%, IPI +1.8%, DAC +1.7%, CVS +1.6%, ETR +1.5%, NRZ +1.5%, AET +1.4%, ENOC +1.4%, STX+1.4%, PG +1.2%, VGZ +1.2%, PRSC +1.1%, SBRA +1%, TST +0.9%, DISCA +0.9%
M&A news:
- CBIO +11.1% (to sell to Attenua certain oral Neuronal Nicotinic Receptor assets; may receive up to $105 mln in milestone payments plus royalties on net sales)
- NYRT +3.9% (New York REIT and The JBG Cos mutually agree to terminate their previously announced master combination agreement)
- SLW +1.5% (to acquire from Vale S.A (VALE) an additional amount of gold equal to 25% of the life of mine gold production from its Salobo mine; co gives new production guidance)
Other news:
- TRXC +30% (announces the first global sale of its ALF-X Surgical Robotic System to Humanitas Hospital in Milan, Italy)
- NXTD +10.7% (announces the issuance of patent by the USPTO for risk aware end to end multi-factor authentication )
- PSTI +10.3% (announces that it received positive feedback from the FDA on the proposed Phase III trial of its PLX-PAD cells in the treatment of critical limb ischemia), CTRV +9.8% (announces positive top-line results from Phase 1b multiple ascending dose clinical safety study of CMX157)
- KOOL +6.3% (announces that data for its proprietary technology was published in the Herald Scholarly Open Access Journal of Stem Cells Research, Development and Therapy)
- WSTL +5.5% (Cove Street Capital discloses 16.3% active stake, has entered into confidentiality agreement with the company)
- HZNP +3.8% ( secures covered status for DUEXIS and VIMOVO with CVS/Caremark (CVS))
- HRTX +3.4% (announces a 2-year term $100 mln loan agreement with Tang Capital Partners)
- BITA +1.8% ( announces that an investor consortium comprised of Tencent (TCEHY), JD.com (JD), and other investors to make investments totaling $550 mln in cash in subsidiary, Yixin Capital),
- DGLY +1.5% (receives three-year supply contract exceeding $1.0 mln for body cameras, service and storage systems),
- DRQ +1.1% (Dril-Quip discloses discloses amendment to its four-year contract with Petrobras ), .
Analyst comments:
- NEM +1.3% (initiated with a Buy at Citigroup)
- FORM +1.1% (upgraded to Buy from Hold at Stifel)
- ABX +1% (initiated with a Buy at Citigroup)
- AEO +0.8% (upgraded to Buy from Neutral at BofA/Merrill)
Tullett Prebon targets broking team boost as ICAP deal nears end
Tullett Prebon will look to hire more teams of brokers that trade over the phone even as it closes in on its transformative deal to buy the global broking business of rival ICAP.
The all-share deal worth about £1.1bn hit a snag in July when British antitrust authorities said the combination could create a dominant position in oil trading.
ICAP is set to announce the sale later today of its oil broking team to offset the concerns, according to two people familiar with the situation. ICAP declined to comment. It came as Tullett said energy market volatility had boosted interim earnings. Its shares rose 0.8 per cent in morning trade in London.
Approval by the UK would smooth the way for Tullett to surpass US-based BGC Partners and become the world’s largest hybrid voice and electronic interdealer broker by market share. It would dominate an over-the-counter market where brokers help move illiquid and large deals in foreign exchange, commodities, energy and fixed income between counterparties. US and Singaporean authorities have passed the deal. The oil trading business that ICAP will sell generates about £20m in revenues.
“It looks like we’re going to avoid a lengthy investigation, but it wasn’t our intention to divest anything. It’s a relatively modest requirement in the big scheme of things but we’ll take it and move on,” said John Phizackerley, chief executive of Tullett Prebon. “We still have ambitions in energy . . . results showed energy was one of the standout performers.”
Mr Phizackerley said he would be “grazing” the industry for more specialised teams, exemplified in its purchase last week of 14 brokers at Creditex, a US credit derivatives trading business, from Intercontinental Exchange.
“Creditex is significant in that if all we did was integrate ICAP over the next three years, we’d wake up and find out that the world had moved on. Integrating ICAP is the number one priority but we continue to look out for high touch businesses,” he added.
For the six months to June 30, revenues at Tullett rose 4 per cent to £430.3m. Earnings were boosted by data sales and a stronger performance in energy, commodity and equity products. Pre-tax profit rose from £52.9m to £60.3m as it also cut the amount of revenue it paid to its brokers.
Tullett also announced it was setting up a new technology centre in Belfast to focus on development and technical support. It will save the company about £5m a year on technology costs and the figure might double with the integration of the ICAP business. It would be on top of the £60m savings Tullett has targeted from the ICAP deal.
Tullett also said it was too early to speculate on the long-term impact of the UK’s decision to leave the European Union but it has benefited recently from increased levels of market volatility.
Early premarket gappers
Gapping up: TRXC +30.8%, HBP +19%, CGNX +14.7%, AMKR +13.2%, NLS+9.8%, OMEX +8.8%, GKOS +7.6%, VGZ +6.3%, WSTL +5.5%, AEIS +4.9%, TSE+4.1%, RYAM +3.9%, MNK +3.9%, WPZ +3.8%, WMB +3.7%, SHPG +3.5%, TNET+3%, ABC +3%, CHGG +2.9%, GAIN +2.7%, AVGR +2.4%, WCG +2.1%, DNB+1.9%, ATW +1.9%, IPI +1.8%, DAC +1.7%, HMC +1.5%, DRQ +1.1%, PRSC+1.1%, SBRA +1%, ETN +1%, TST +0.9%, RDC +0.8%, ININ +0.7%, NRZ +0.7%,WNR +0.7%
Gapping down: BCEI -29.9%, IDTI -17.1%, RAIL -16.4%, TXRH -10.5%, TTOO-9.8%, GLOP -6.3%, ALLT -5.7%, BGSF -5.5%, QUAD -4.9%, ANGO -4.6%, MZOR-4.3%, FELP -4.2%, FTR -4.1%, THC -3.8%, AVP -3.6%, AQMS -3.5%, GGP-3.5%, BRX -2.9%, PTN -2.9%, ELLI -1.8%, CGEN -1.6%, APTS -1.2%, PFE-0.8%, ATKR -0.5%
Gapping down: BCEI -29.9%, IDTI -17.1%, RAIL -16.4%, TXRH -10.5%, TTOO-9.8%, GLOP -6.3%, ALLT -5.7%, BGSF -5.5%, QUAD -4.9%, ANGO -4.6%, MZOR-4.3%, FELP -4.2%, FTR -4.1%, THC -3.8%, AVP -3.6%, AQMS -3.5%, GGP-3.5%, BRX -2.9%, PTN -2.9%, ELLI -1.8%, CGEN -1.6%, APTS -1.2%, PFE-0.8%, ATKR -0.5%